DK0623614T3 - 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase - Google Patents
4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenaseInfo
- Publication number
- DK0623614T3 DK0623614T3 DK94303012T DK94303012T DK0623614T3 DK 0623614 T3 DK0623614 T3 DK 0623614T3 DK 94303012 T DK94303012 T DK 94303012T DK 94303012 T DK94303012 T DK 94303012T DK 0623614 T3 DK0623614 T3 DK 0623614T3
- Authority
- DK
- Denmark
- Prior art keywords
- aryl
- hydroxy
- tetrahydropyrans
- tetrahydrofurans
- lipoxygenase
- Prior art date
Links
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 title 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93401120 | 1993-04-29 | ||
| EP93401991 | 1993-08-02 | ||
| EP94400190 | 1994-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0623614T3 true DK0623614T3 (da) | 1998-09-28 |
Family
ID=27235558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94303012T DK0623614T3 (da) | 1993-04-29 | 1994-04-26 | 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5478842A (da) |
| EP (1) | EP0623614B1 (da) |
| JP (1) | JP3553127B2 (da) |
| KR (1) | KR100358464B1 (da) |
| CN (1) | CN1052002C (da) |
| AP (1) | AP9400632A0 (da) |
| AT (1) | ATE163417T1 (da) |
| AU (1) | AU681886B2 (da) |
| CA (1) | CA2121199C (da) |
| CZ (1) | CZ280695A3 (da) |
| DE (1) | DE69408593T2 (da) |
| DK (1) | DK0623614T3 (da) |
| ES (1) | ES2112483T3 (da) |
| FI (2) | FI109123B (da) |
| GB (1) | GB9408001D0 (da) |
| HK (1) | HK1004777A1 (da) |
| HU (1) | HU9502968D0 (da) |
| IL (1) | IL109254A (da) |
| NO (1) | NO309191B1 (da) |
| NZ (1) | NZ266139A (da) |
| PL (1) | PL311300A1 (da) |
| SK (1) | SK134995A3 (da) |
| TW (1) | TW252978B (da) |
| WO (1) | WO1994025453A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3990972B2 (ja) * | 2001-11-20 | 2007-10-17 | 有限会社 キック | 血管再狭窄防止薬及び該防止薬がコーティングされた血管内埋め込み器具 |
| SE0104274D0 (sv) * | 2001-12-17 | 2001-12-17 | Astrazeneca Ab | Novel process |
| DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
| US8158362B2 (en) | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
| WO2007087250A2 (en) | 2006-01-23 | 2007-08-02 | Amira Pharmaceuticals, Inc. | Tricyclic inhibitors of 5-lipoxygenase |
| JP2010511632A (ja) | 2006-11-30 | 2010-04-15 | アミラ ファーマシューティカルス，インコーポレーテッド | ５−リポキシゲナーゼ活性化タンパク質インヒビターおよび一酸化窒素モジュレーターを含んでいる組成物および治療法 |
| US10793515B2 (en) * | 2008-03-19 | 2020-10-06 | Aurimmed Pharma, Inc. | Compounds advantageous in the treatment of central nervous system diseases and disorders |
| US20210130285A1 (en) | 2008-03-19 | 2021-05-06 | Aurimmed Pharma, Inc. | Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| WO2015120038A1 (en) | 2014-02-04 | 2015-08-13 | Bioscience Pharma Partners, Llc | Use of flap inhibitors to reduce neuroinflammation mediated injury in the central nervous system |
| ES2760466T3 (es) | 2015-05-04 | 2020-05-14 | Astrazeneca Ab | Derivados de pirazol útiles como inhibidores de la proteína activadora de 5-lipoxigenasa (FLAP) |
| JP7041146B2 (ja) | 2016-10-28 | 2022-03-23 | アストラゼネカ・アクチエボラーグ | （１Ｒ，２Ｒ）－２－［４－（３－メチル－１Ｈ－ピラゾール－５－イル）ベンゾイル］－Ｎ－（４－オキソ－４，５，６，７－テトラヒドロピラゾロ［１，５－ａ］ピラジン－３－イル）シクロヘキサンカルボキサミド |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4794188A (en) * | 1982-12-01 | 1988-12-27 | Usv Pharmaceutical Corporation | Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity |
| US4567184A (en) * | 1982-12-01 | 1986-01-28 | Usv Pharmaceutical Corporation | Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies |
| US4625034A (en) * | 1985-02-04 | 1986-11-25 | Usv Pharmaceutical Corp. | 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives |
| US4631287A (en) * | 1985-04-16 | 1986-12-23 | Usv Pharmaceutical Corp. | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4728668A (en) * | 1985-04-16 | 1988-03-01 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4725619A (en) * | 1985-04-16 | 1988-02-16 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4868193A (en) * | 1986-09-24 | 1989-09-19 | Rorer Pharmaceutical Corporation | Styryl tetrazoles and anti-allergic use thereof |
| GB8926981D0 (en) * | 1988-12-23 | 1990-01-17 | Ici Plc | Heterocyclic derivatives |
| US5234950A (en) * | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
| US5202326A (en) * | 1989-02-28 | 1993-04-13 | Imperial Chemical Industries Plc | Heterocyclic ethers |
| US5134148A (en) * | 1989-02-28 | 1992-07-28 | Imperial Chemical Industries Plc | Heterocycles for use as inhibitors of leukotrienes |
| US5236919A (en) * | 1989-02-28 | 1993-08-17 | Imperial Chemical Industries Plc | Quinoxalinyl derivatives suitable for use in leukotriene mediated disease |
| IE70521B1 (en) * | 1989-02-28 | 1996-12-11 | Zeneca Pharma Sa | Heterocycles with inhibitory activity of 5-lipoxygenase |
| IE64358B1 (en) * | 1989-07-18 | 1995-07-26 | Ici Plc | Diaryl ether heterocycles |
| GB9018134D0 (en) * | 1989-09-29 | 1990-10-03 | Ici Plc | Heterocyclic derivatives |
| US5088927A (en) * | 1990-06-18 | 1992-02-18 | Lee Howard G | Radio opaque plastics and process of making |
| IE911919A1 (en) * | 1990-06-21 | 1992-01-01 | Zeneca Ltd | Bicyclic heterocyclic compounds |
| IE911853A1 (en) * | 1990-06-21 | 1992-01-01 | Ici Plc | Heterocyclene derivatives |
| GB9113137D0 (en) * | 1990-07-13 | 1991-08-07 | Ici Plc | Thioxo heterocycles |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| US5272173A (en) * | 1990-11-28 | 1993-12-21 | Imperial Chemical Industries Plc | 5-lipoxygenase inhibitors |
| EP0501579A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Naphthalene lactones as inhibitors of leukotriene biosynthesis |
| EP0501578A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| US5308852A (en) * | 1992-06-29 | 1994-05-03 | Merck Frosst Canada, Inc. | Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
-
1994
- 1994-04-07 AP APAP/P/1994/000632A patent/AP9400632A0/en unknown
- 1994-04-07 IL IL10925494A patent/IL109254A/en not_active IP Right Cessation
- 1994-04-13 CA CA002121199A patent/CA2121199C/en not_active Expired - Fee Related
- 1994-04-22 GB GB9408001A patent/GB9408001D0/en active Pending
- 1994-04-25 HU HU9502968A patent/HU9502968D0/hu unknown
- 1994-04-25 CZ CZ952806A patent/CZ280695A3/cs unknown
- 1994-04-25 NZ NZ266139A patent/NZ266139A/xx not_active IP Right Cessation
- 1994-04-25 SK SK1349-95A patent/SK134995A3/sk unknown
- 1994-04-25 WO PCT/EP1994/001277 patent/WO1994025453A1/en not_active Ceased
- 1994-04-25 PL PL94311300A patent/PL311300A1/xx unknown
- 1994-04-25 CN CN94191925A patent/CN1052002C/zh not_active Expired - Fee Related
- 1994-04-25 KR KR1019950704723A patent/KR100358464B1/ko not_active Expired - Fee Related
- 1994-04-25 AU AU67212/94A patent/AU681886B2/en not_active Ceased
- 1994-04-26 JP JP08882694A patent/JP3553127B2/ja not_active Expired - Fee Related
- 1994-04-26 DE DE69408593T patent/DE69408593T2/de not_active Expired - Fee Related
- 1994-04-26 DK DK94303012T patent/DK0623614T3/da active
- 1994-04-26 EP EP94303012A patent/EP0623614B1/en not_active Expired - Lifetime
- 1994-04-26 ES ES94303012T patent/ES2112483T3/es not_active Expired - Lifetime
- 1994-04-26 AT AT94303012T patent/ATE163417T1/de not_active IP Right Cessation
- 1994-04-28 US US08/234,148 patent/US5478842A/en not_active Expired - Lifetime
- 1994-04-30 TW TW083103922A patent/TW252978B/zh active
-
1995
- 1995-05-12 US US08/440,132 patent/US5512594A/en not_active Expired - Lifetime
- 1995-10-27 FI FI955165A patent/FI109123B/fi active
- 1995-10-27 NO NO954321A patent/NO309191B1/no not_active IP Right Cessation
-
1998
- 1998-05-05 HK HK98103836A patent/HK1004777A1/en not_active IP Right Cessation
-
2002
- 2002-02-11 FI FI20020270A patent/FI20020270A7/fi unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0922697T3 (da) | Substituerede pyrazolylbenzensulfonamider og anvendelse deraf som cyclooxygenase II-inhibitorer | |
| FI962315L (fi) | Entsyymi-inhibiittorit | |
| NO942064D0 (no) | yminhibitorer | |
| FI20012510L (fi) | Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina | |
| FI941767L (fi) | 1H-indoli-3-asetamidi sPLA2 inhibiittoreita | |
| FI965019A7 (fi) | Entsyymi-inhibiittoreita | |
| HU9303218D0 (en) | Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia | |
| DK0811006T3 (da) | Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse | |
| NO932620D0 (no) | Amindiol-proteaseinhibitorer | |
| EP0693083A4 (en) | ALPHACETOAMIDE DERIVATIVES USEFUL AS THROMBOSIS INHIBITORS | |
| FI944259L (fi) | Käytettävyysprosessori ja -menetelmä | |
| FI963597A7 (fi) | Isoprenyylitransferaasi-inhibiittoreita | |
| NO972930D0 (no) | Fibronectin-adhesjonsinhibitorer | |
| NO942247L (no) | Korrosjonsinhibitor og anvendelse derav | |
| DK0462813T3 (da) | Bicykliske pyranderivater og deres anvendelse som 5-lipoxygenasehæmmere | |
| DK0944590T3 (da) | Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer | |
| FI961857A7 (fi) | Matriksin metalloproteaasien inhibiittorit | |
| FI942625L (fi) | Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina | |
| PT927183E (pt) | Inibidores espirociclicos de metaloproteases | |
| FI960482A7 (fi) | Matriksin metalloproteaasien inhibiittorit | |
| FI953851L (fi) | Silybidut asetyylikoliiniesteraase-inhibiittorit | |
| NO954321L (no) | 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer | |
| NO962015D0 (no) | Pyron-derivater som protease-inhibitorer og antivirus-midler | |
| DE69431454D1 (de) | Amylase Inhibitoren | |
| NO961733D0 (no) | Fremgangsmåte for desinfisering og törking |